Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1373848

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1373848

Global Contraceptives Market Size, Share, Growth Analysis, By Type(oral contraceptives (birth control pills), intrauterine devices (IUDs)) - Industry Forecast 2023-2030

PUBLISHED:
PAGES: 157 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Contraceptives Market size was valued at USD 23.20 billion in 2021 and is poised to grow from USD 28.22 billion in 2022 to USD 49.96 billion by 2030, growing at a CAGR of 7.4% in the forecast period (2023-2030).

The global contraceptives market is witnessing significant growth and is driven by several factors. Increasing awareness about family planning, rising prevalence of sexually transmitted infections (STIs), and the growing demand for effective contraceptive methods are key factors contributing to market growth. Additionally, advancements in contraceptive technologies, such as the development of long-acting reversible contraceptives (LARCs) and the availability of a wide range of contraceptive options, are further fueling market expansion. Moreover, government initiatives and programs aimed at promoting family planning and reproductive health are creating a favorable environment for the market. However, challenges such as social stigma, cultural barriers, and limited access to contraceptives in certain regions pose restraints to market growth. Nonetheless, the increasing emphasis on women's health and the rising acceptance of contraception as a means of empowerment are expected to drive the growth of the global contraceptives market in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Emergency Lighting Systems Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Contraceptives Market Segmental Analysis

The global contraceptives market is segmented by type, application, and region. Based on type, the market can be segmented into oral contraceptives (birth control pills), intrauterine devices (IUDs), condoms, contraceptive patches, injectable contraceptives, and more. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Contraceptives Market Dynamics

Drivers of the Global Contraceptives Market

Increasing Awareness And Acceptance Of Family Planning And Reproductive Health

One key driver of the global contraceptives market is the increasing awareness and acceptance of family planning and reproductive health. As societies become more educated and aware about the importance of contraception in controlling population growth and promoting women's health, the demand for contraceptives has witnessed significant growth. Additionally, government initiatives and programs aimed at promoting family planning, along with the efforts of various organizations in spreading awareness about contraceptive methods, have also contributed to the market's growth.

Restraints in the Global Contraceptives Market

Cultural And Religious Barriers That Limit The Use And Acceptance Of Contraceptives

A major restraint in the global contraceptives market is the cultural and religious barriers that limit the use and acceptance of contraceptives in certain regions. In some societies, there are cultural or religious beliefs that discourage or restrict the use of contraceptives, leading to lower adoption rates. Moreover, inadequate access to contraceptives, particularly in rural and remote areas, can also act as a restraint. Limited availability, affordability, and lack of proper distribution channels can hinder the widespread use of contraceptives, especially in developing countries. Overcoming these cultural and logistical challenges is crucial for the market's further growth and ensuring universal access to effective contraception methods.

Market Trends of the Global Contraceptives Key

One key market trend in the global contraceptives market is the increasing demand for long-acting reversible contraceptives (LARCs). LARCs include methods such as intrauterine devices (IUDs) and contraceptive implants. These methods offer a high level of effectiveness and convenience, as they require less frequent administration compared to other contraceptive options. LARCs are preferred by women seeking reliable and hassle-free contraception, contributing to their growing popularity. Additionally, advancements in technology have led to the development of more innovative and user-friendly LARCs, further driving their adoption. The trend towards LARCs reflects a shift towards more effective and sustainable contraceptive methods in the global market.

Product Code: SQMIG35I2174

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
    • Regulatory Landscape
    • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Contraceptives Market by Type
    • Market Overview
    • oral contraceptives (birth control pills)
    • intrauterine devices (IUDs)
    • condoms
    • contraceptive patches
    • injectable contraceptives
    • and more
  • Global Contraceptives Market Size by Region
    • Market Overview
    • North America
  • USA
  • Canada
    • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
    • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
    • Latin America
  • Brazil
  • Rest of Latin America
    • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
  • By Development
  • By Company
  • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • Pfizer Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Merck & Co., Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Johnson & Johnson Services, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Mylan N.V. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Allergan plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Reckitt Benckiser Group plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Church & Dwight Co., Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Mankind Pharma Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • CooperSurgical, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Medisafe Distribution Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • HLL Lifecare Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Mayer Laboratories, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Lupin Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Okamoto Industries, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Actavis, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Ansell Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Cipla Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • anssen Pharmaceuticals, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!